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Background
Myelination and neurite outgrowth both occur during brain development and their disturbance has
been previously implicated in the pathophysiology of schizophrenia. Leucine-rich repeat and
immunoglobulin domain-containing protein (Lingo-1), is a potent negative regulator of axonal
myelination and neurite extension. Since co-factors of Lingo-1 signaling (Nogo receptor (NgR),
With No Lysine (K) (WNK1) and Myelin transcription factor 1 (Myt1)) have been previously
implicated in the genetics of schizophrenia, we explored for the first time the role of Lingo-1
signaling pathways in this disorder. Lingo-1 protein, together with its co-receptor and cofactor
proteins NgR, TNF receptor orphan Y (TROY), p75, WNK1 and Myt1, have never been explored
in the pathogenesis of schizophrenia.

Methods
We examined protein levels of Lingo-1, NgR, TROY, p75, WNK1 and Myt1 within the postmortem dorsolateral prefrontal cortex (DLPFC), a brain region highly disrupted in schizophrenia
pathophysiology; from 37 schizophrenia patients versus 37 matched controls from the NSWBrain
Bank Network.

Results
Lingo-1 protein expression was found to be significantly increased by 12% (p=0.006) in the
DLPFC of schizophrenia subjects. A significant 19.5% increase in Lingo-1 expression was found
in schizophrenia males compared to control males (p<0.001).
In contrast to Lingo-1, NgR protein expression was significantly decreased by 16% (p<0.001).
Interestingly, neither the third receptor in this trimolecular receptor complex p75, nor its homolog
TROY, showed any significant difference in levels of protein expression in schizophrenia subjects
compared to controls (p=0.146 and p=0.500 respectively). Analysis of WNK1 revealed no
statistically significant difference in expression in the DLPFC between schizophrenia and control
subjects (p=0.864).However a significant 11.5% increase in Myt1 expression was observed in
schizophrenia compared to control groups (p=0.023).

Conclusions
This is the first study to examine the expression profile of Lingo-1 and its signaling partner
proteins in schizophrenia, identifying alterations of these pathways in the DLPFC from
schizophrenia patients. Further analysis will be required to characterize these interactions at a
molecular and cell specific level. However, this innovative finding provides the first foundation
for a new avenue in the development of future therapies for schizophrenia.

	
  

	
  

